Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$9.81 - $15.4 $196,916 - $309,124
-20,073 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $29,366 - $35,657
-2,429 Reduced 10.79%
20,073 $272,000
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $7,963 - $9,093
-601 Reduced 2.6%
22,502 $305,000
Q2 2021

Sep 09, 2021

SELL
$12.97 - $16.15 $22,152 - $27,584
-1,708 Reduced 6.88%
23,103 $330,000
Q1 2021

Sep 09, 2021

SELL
$13.59 - $18.54 $1,318 - $1,798
-97 Reduced 0.39%
24,811 $347,000
Q4 2020

Sep 09, 2021

BUY
$14.3 - $18.74 $356,184 - $466,775
24,908 New
24,908 $467,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track J.P. Marvel Investment Advisors, LLC Portfolio

Follow J.P. Marvel Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.P. Marvel Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J.P. Marvel Investment Advisors, LLC with notifications on news.